M-A | Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis. SPECIALTIES, 21 Oct 2022 Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis…